All In Biotech

Drug Trial Radar · NCT04264806

A Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT)

A Phase 2, Randomized, Open-label Study of Cusatuzumab in Combination With Azacitidine Compared With Azacitidine Alone in Patients With Higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) and Who Are Not Candidates for Hematopoietic Stem Cell Transplantation (HSCT)

Last checked: Nov 19, 2026Latest source record: May 20, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

May 6, 2021

Primary completion

Apr 19, 2022

Study completion Jan 28, 2025

Sponsor

Lead sponsor
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
Collaborators
argenx
First posted
Feb 11, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to compare overall response rate (ORR) between treatment groups in participants with higher-risk Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) who are not eligible for Hematopoietic Stem Cell Transplantation (HSCT).

Conditions

  • Myelodysplastic Syndromes
  • Leukemia, Myelomonocytic, Chronic

Interventions

  • AzacitidineDrug

    Participants will receive subcutaneous (SC) or intravenous (IV) injection of Azacitidine 75 mg/m\^2.

  • CusatuzumabDrug

    Participants will receive SC or IV injection of Cusatuzumab 20 mg/kg.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Response Rate (ORR)Time frame: Up to 4 years

Locations

73 sites in 11 countries. Site status is shown where the registry gives one.

  • St Vincents Hospital Sydney

    Darlinghurst, Australia

  • St Vincents Hospital Melbourne

    Fitzroy, Australia

  • Peter MacCallum Cancer Institute

    Melbourne, Australia

  • Royal Perth Hospital

    Perth, Australia

  • Westmead Hospital

    Westmead, Australia

  • Wollongong Hospital

    Wollongong, Australia

  • Hospital Erasto Gaertner- Liga Paranaense de Combate ao Câncer

    Curitiba, Brazil

  • Cepon - Centro De Pesquisas Oncologicas

    Florianópolis, Brazil

  • Liga Norte Riograndense Contra O Cancer

    Natal, Brazil

  • Hospital de Clínicas de Porto Alegre

    Porto Alegre, Brazil

  • Instituto do cancer -COR -Hospital Mae de Deus

    Porto Alegre, Brazil

  • Oncoclínicas

    Rio de Janeiro, Brazil

  • Hospital de Base de São José do Rio Preto

    São José do Rio Preto, Brazil

  • Hospital Paulistano

    São Paulo, Brazil

  • Instituto D'Or de Pesquisa e Ensino (IDOR)

    São Paulo, Brazil

  • CHU d'Angers

    Angers, France

  • Hopital Saint Vincent de Paul

    Lille, France

  • CHU de Limoges, Hopital Dupuytren

    Limoges, France

  • Hôpital de La Conception

    Marseille, France

  • CHU de Nice Hopital de l Archet

    Nice, France

  • Hopital Saint-Louis

    Paris, France

  • Hopital Cochin APHP

    Paris, France

  • CHRU Tours Hôpital Bretonneau

    Tours, France

  • CHU de Nancy_ Hôpital Brabois

    Vandœuvre-lès-Nancy, France

  • Universitatsklinikum Carl Gustav Carcus Dresden

    Dresden, Germany

  • Universitätsklinik Freiburg

    Freiburg im Breisgau, Germany

  • Medizinische Hochschule Hannover

    Hanover, Germany

  • Universitatsklinikum Leipzig

    Leipzig, Germany

  • Klinikum rechts der Isar an der Technischen Universität München

    München, Germany

  • Universitaetsklinikum Ulm

    Ulm, Germany

  • Policlinico Sant'Orsola Malpighi

    Bologna, Italy

  • Azienda Ospedaliero Universitaria di Ferrara

    Cona, Italy

  • Università del Piemonte Orientale - Ospedale Maggiore della Carità di Novara

    Novara, Italy

  • Aou San Luigi Gonzaga

    Orbassano, Italy

  • Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli' Reggio Calabria

    Reggio Calabria, Italy

  • Fondazione Policlinico Tor Vergata

    Roma, Italy

  • Policlinico Umberto I

    Roma, Italy

  • Istituto Clinico Humanitas

    Rozzano, Italy

  • Emergency Hospital of Dzerzhinsk

    Dzerzhinsk, Russia

  • S.P. Botkin Moscow City Clinical Hospital

    Moscow, Russia

Showing 40 of 73 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.